StemCell Institute Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	217	565	441	278	212
Depreciation & Amortization	156	128	120	104	96
Loss (Gain) From Sale of Investments	-	-136	-22	-	-
Other Operating Activities	-184	-148	-111	-108	11
Change in Accounts Receivable	-496	-252	-447	-546	-314
Change in Inventory	-3	-8	-2	-	-8
Change in Accounts Payable	4	-21	18	-10	72
Change in Other Net Operating Assets	379	339	337	381	400
Operating Cash Flow	73	467	334	99	469
Operating Cash Flow Growth	-84.37%	39.82%	237.37%	-78.89%	97.06%
Capital Expenditures	-409	-478	-183	-56	-181
Cash Acquisitions	-	-34	-	-	-
Sale (Purchase) of Intangibles	-117	-96	-18	-3	-23
Investment in Securities	-200	357	-627	-142	750
Other Investing Activities	-18	-9	17	-84	-142
Investing Cash Flow	-744	-259	-811	-285	404
Long-Term Debt Issued	-	510	-	-	-
Long-Term Debt Repaid	-63	-11	-	-	-
Net Debt Issued (Repaid)	-63	499	-	-	-
Issuance of Common Stock	-	-	-	-	644
Repurchase of Common Stock	-106	-94	-	-	-
Common Dividends Paid	-	-255	-	-	-
Other Financing Activities	400	-4	-1	-	-
Financing Cash Flow	231	146	-1	-	644
Foreign Exchange Rate Adjustments	35	-	-	-	-
Miscellaneous Cash Flow Adjustments	1	1	-	-	-
Net Cash Flow	-404	355	-478	-186	1,517
Free Cash Flow	-336	-11	151	43	288
Free Cash Flow Growth	-	-	251.16%	-85.07%	-
Free Cash Flow Margin	-11.95%	-0.41%	6.09%	2.06%	16.17%
Free Cash Flow Per Share	-33.27	-1.07	14.74	4.20	56.87
Cash Interest Paid	5	1	-	-	-
Cash Income Tax Paid	184	144	110	109	-8
Levered Free Cash Flow	-543.25	7.25	56.75	56.25	236.88
Unlevered Free Cash Flow	-540.13	7.88	56.75	56.25	236.88
Change in Working Capital	-116	58	-94	-175	150